|
4-methyl-2-(4-methylphenyl)-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
4-methyl-2-phenyl-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
Depiction based on curated SMILES
N
N
N
O
N
O
N
O
CH
3
O
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
6-(4-((2,4-dimethylphenyl)sulfonyl)piperazin-1-yl)-N-(pyridin-4-yl)pyridazin-3-amine |
Depiction based on curated SMILES
N
N
N
N
H
CH
3
N
N
O
O
S
CH
3
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
Cyto10C9 |
Depiction based on curated SMILES
Cl
Cl
N
H
N
CH
3
N
N
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
1-(2,4-dimethoxybenzyl)-4-(2,3-dimethylphenyl)piperazine |
Depiction based on curated SMILES
H
3
C
O
CH
3
H
3
C
CH
3
N
N
O
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
3-cyclohexyl-1-[4-(2-methoxyphenyl)piperazin-1-yl]propan-1-one |
Depiction based on curated SMILES
O
CH
3
N
N
O
|
Clostridium |
TcdB (Toxin B) |
Preclinical (in vitro) |
Farrow MA, et al. 2020. ACS Chem Biol |
|
Piperazinehexanamide derivative, 5 |
Depiction based on curated SMILES
N
H
O
CH
3
N
N
S
|
Coxiella Legionella |
Dot/Icm T4SS Dot/Icm (Defect in organella trafficking/intracellular multiplication) |
Preclinical (in vitro) Preclinical (in vitro) |
Cheng E, et al. 2022. mBio
|
|
N-{1-[4-(4-FLUOROPHENYL)PIPERAZIN-1-YL]-1-(THIOPHEN-2-YL)PROPAN-2-YL}-N'-[(PYRIDIN-3-YL)METHYL]ETHANEDIAMIDE |
Depiction based on curated SMILES
HN
F
HN
O
O
N
S
N
CH
3
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Chen L, et al. 2010. ACS Med Chem Lett |
|
N-[(FURAN-2-YL)METHYL]-N'-{1-[4-(4-METHOXYPHENYL)PIPERAZIN-1-YL]-1-(THIOPHEN-2-YL)PROPAN-2-YL}ETHANEDIAMIDE |
Depiction based on curated SMILES
O
O
H
3
C
HN
O
HN
O
S
N
CH
3
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Chen L, et al. 2010. ACS Med Chem Lett |
|
furo[3,2-b]quinoxalin-3-yl-(4-phenylpiperazin-1-yl)methanone |
Depiction based on curated SMILES
N
N
N
O
N
O
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother |
|
| | |